EUVIMEDEUVIMED entdecken
LeserbriefSystematische ÜbersichtMetaanalyse

Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis

Ke Xu

Medical Ultrasonography · 2024

DOI: 10.11152/mu-4429 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Medical Ultrasonography, 2024. Verfasst von Ke Xu. Beteiligte Einrichtung: Ultrasound Department, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China. xuke808080@163.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Contrast Media, Liver Neoplasms, Ultrasonography.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularContrast MediaLiver NeoplasmsUltrasonographyHumansFerric CompoundsIronOxidesReproducibility of ResultsSensitivity and SpecificityMeta-Analysis as TopicSystematic Reviews as Topic

Substanzen

Contrast MediaFerric CompoundsIronOxidesSonazoid

Autor:innen und Institutionen

  • Ultrasound Department, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China. xuke808080@163.com.

Zitieren

APA

Xu, K. (2024). Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis. Medical Ultrasonography. https://doi.org/10.11152/mu-4429

Vancouver

Xu K. Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis. Medical Ultrasonography. 2024. doi:10.11152/mu-4429

BibTeX
@article{Xu2024,
  author = {Xu, Ke},
  title = {Comment to: Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis},
  journal = {Medical Ultrasonography},
  year = {2024},
  doi = {10.11152/mu-4429}
}
Kostenlos starten →